| Literature DB >> 35915721 |
Félix Javier Jiménez-Jiménez1, Hortensia Alonso-Navarro1, Elena García-Martín2, José A G Agúndez2.
Abstract
Sleep disorders seem to be a frequent complaint of patients diagnosed with Tourette syndrome (TS) or chronic or persistent tic disorders (CTD or PTD). In this review, we expanded a previously used search using 4 well-known databases up to February 15, 2022, looking for the coexistence of global and/or specific sleep disorders and polysomnographic studies performed on patients with TS/CTD/PTD. The references of interest in the topic were selected by hand. Sleep disorders in general, insomnia, different arousal disorders, the persistence of tics during sleep, excessive daytime sleepiness, and periodic limb movements during sleep (PLMS) were very frequent in patients with TS, most of them being more frequent in patients with comorbid Attention Deficit Hyperactivity Disorder. The most frequent results from polysomnographic studies were decreased sleep efficiency and increased sleep onset latency. Many of these findings could be related to medication used for the treatment of tics and comorbid disorders.Entities:
Keywords: Tourette syndrome; arousal disorders; hypersomnia; insomnia; periodic limb movements during sleep; sleep disorders
Year: 2022 PMID: 35915721 PMCID: PMC9338347 DOI: 10.2147/NSS.S340948
Source DB: PubMed Journal: Nat Sci Sleep ISSN: 1179-1608
Studies on the Prevalence of Sleep Disorders in Tourette Syndrome
| Authors, Year ReF | Country | Definition Criteria and Setting | Study Subjects and Treatment | Main Findings |
|---|---|---|---|---|
| Moldofski et al, 1974 | Canada | Sleep disturbances (difficulty in sleep onset and/or frequent nocturnal arousals) assessed using a specific questionnaire | 15 patients diagnosed with TS, most of these adults (14 male, mean age at onset of motor and vocal tics 7.7 and 10.3 years, all treated with haloperidol) | Prevalence of sleep disturbances: 80% |
| Nee et al, 1980 | United States of America | Sleep disturbances assessed by clinical interview | 50 patients diagnosed with TS (mean age at onset 7.0 years, sex not specified, 46 were treated with haloperidol) | Prevalence of sleep disturbances: 44% (53.1% in patients with a family history of TS or tics and 27.8% in those without a family history of TS or tics) |
| Glaze et al, 1983 | United States of America | Sleep disturbances (including enuresis, somnambulism, and frequent awakenings). Assessment of sleep disorders by PSG and video monitoring | 14 untreated patients diagnosed with TS (9 men; 7 aged 8–19 years and 2 aged 48 years) | Prevalence of sleep disturbances: 42.9% (60% in patients with a family history of TS or tics and 0% in those without a family history of TS or tics) |
| Barabas et al, 1984 | United States of America | Sleep disturbances | 57 patients diagnosed with TS (50 boys, age 5–21 years, treatment not specified) | Prevalence of sleep disturbances: 38.6% (this was significantly higher than in 57 patients with seizure disorders −10.3%- and 53 with learning disabilities - 17%). |
| Erenberg, 1985 | United States of America | Sleep disturbances | 58 patients diagnosed with TS aged 15 to 25 years (average 17 years), sex and medication not specified | Prevalence of sleep disturbances: 22.4% (6 patients had nightmares. none of them had enuresis or somnambulism). |
| Jankovic & Rohaidy, 1987 | United States of America | Sleep complaints | 112 patients diagnosed with TS (male-to-female ratio 3.8, mean age at onset 7.3, average duration of the symptoms 15.2 years; most of them treated with neuroleptics or tetrabenazine, 27 with clonidine, and 13 with clonazepam) | Prevalence of sleep complaints: 61.6% (the most frequent were the persistence of tics during sleep −19.6%, and enuresis −17.0%). |
| Comings & Comings, 1987 | United States of America | Mean sleep problems score | 246 TS patients, 197 males, age ranges 2–75 years, mean age at onset 6.65 years; 39% have received treatment for ADHD or behavior problems | Significantly higher “mean sleep problems score” in patients with severe TS and TS + ADHD patients than in controls. |
| Freeman et al, 2000 | Canada | Sleep disorders assessed as a part of a global questionnaire of comorbidities | 2846 males and 654 females diagnosed with TS, ADHD, or OCD (mean age at onset 6.4 years, treatment not specified) | Prevalence of sleep disorders: 25% in males and 26% in females |
| Teive et al, 2001 | Brasil | Sleep disorders assessed by clinical interview | 44 patients diagnosed with TS or other tic disorders. Treatment not specified | Prevalence of sleep disturbances: 9.1% |
| Saccomani et al, 2005 | Italy | Sleep problems assessed with a specific questionnaire to parents (increased number of arousals, poor sleep efficiency, increased frequency of sleepwalking, night terrors, sleeptalking, and trouble falling asleep) | 48 patients with TS (36 male, mean age 11.2 years; 26 with OCD, 21 with ADHD), 48 with chronic tic disorder (33 male, mean age 12.1 years; 4 with OCD, 11 with ADHD). Treatment not specified | Prevalence of sleep disturbances: 27.1% in TS, 16.7% in chronic tic disorder, 0% in 30 healthy controls. |
| Storch et al, 2007 | United States of America | Sleep-related problems assessed by 6 specific items from a Child Behavior Checklist and 1 item from a Multidimensional Anxiety Scale for Children | 56 patients diagnosed with TS or other tic disorders. Treatment not specified | Prevalence of “sleep-related problems”: 19.7% with four or more, and 19.6% with none |
| Mol Debes et al, 2008 | Denmark | Scores in the items related with “sleep disturbances” of the Child Behaviour Checklist | 314 patients diagnosed with TS (89.1% males, mean age at onset 12.4 years, 21.7% TS + OCD, 21.4% TS + OCD, 18.2% TS + ADHD + OCD; treatment not clearly specified, although 24 were on methylphenidate and 5 used medications for OCD) | Prevalence of sleep disturbances: 17% (the order of frequency was TS + ADHD + OCD > TS + OCD > TS + ADHD > TS only) |
| Ghosh et al, 2014 | United States of America | Sleep disorders | 123 patients diagnosed with TS (48 TS-only and 75 TS + ADHD; mean age 13.6 ± 3.8 years, range 6–21 years; male-to-female ratio 5:1 for TS-only and 3:1 for TS +ADHD). Treatment not specified | Prevalence of sleep disturbances: 64.2% (64.6% in patients with TS only and 64.0% for patients with TS + ADHD) |
| Sambrani et al, 2012 | Germany | Assessment with a clinician reviewed semi-structured questionnaire assessing several comorbidities including sleep problems | 1032 patients diagnosed with TS (978), chronic tics (40), or other tic disorders (529 children, 503 adults, median age 17 years, mean age at onset 6.97 years; male-to-female ratio 3.4/1) Treatment not specified | Prevalence of sleep problems: 26.7% (these showed a strong association with comorbid depression, and a lesser association with ADHD, OCD, and tic severity) |
| Lee et al, 2017 | Taiwan | Sleep disorders | 1124 under 18-year-old patients newly diagnosed with TS between 2001–2007 (76% male, most of them likely untreated). | Prevalence of sleep disorders: 7.24% (significantly higher than that found in a control cohort −3.53%-, the risk was highest in patients with a comorbid anxiety disorder) |
| Groth et al, 2017 | Denmark | Sleep disturbances, assessed by scores in the items related to “sleep disturbances” of the Child Behaviour Checklist | 146 patients diagnosed with TS followed during 4–8 years (median 5.6 years) interviewed at 18.2 years (SD 3.0, range 11.1–25.9). 17.2% of patients of the initial cohort used antipsychotics, 17.1 methylphenidate, 8.8 atomoxetine, 4.4% clonidine, 5.2 melatonin, and 4.8% SSRIs | Prevalence of sleep disorders: 11.1% |
| Ricketts et al, 2018 | United States of America | Telephone survey with a single question regarding nights per week with “sufficient sleep”. Population-based study | 298 patients with current diagnosis of Tourette disorder (TD), 122 with a history of TD, compared with 254 controls, aged 6 to 17 years (66.0%, 48.8%, and 17.3%, respectively, using medications other than vitamins) | Controls showed significantly more nights per week with “sufficient sleep” (6.59) that both TD groups (5.49 and 5.41, there were no significant differences between both TD groups) |
Abbreviations: TS, Tourette syndrome; ADHD, Attention Deficit Hyperactivity Disorder; OCD, Obsessive-Compulsive Disorder; EEG, Electroencephalogram; EMG, Electromyogram; EOG, Electrooculogram; ECG, Electrocardiogram; REM, Rapid Eye Movements; NREM, Non-Rapid Eye Movements; PLMS, Periodic Limb Movements during Sleep.
Studies on the Prevalence of Insomnia in Tourette Syndrome
| Authors, Year Ref | Country | Definition Criteria and Setting | Study Subjects and Treatment | Main Findings |
|---|---|---|---|---|
| Erenberg, 1985 | United States of America | Difficulty falling asleep | 58 patients diagnosed with TS aged 15 to 25 years (average 17 years), sex and medication not specified | Prevalence of difficulty falling asleep: 5.4% |
| Jankovic & Rohaidy, 1987 | United States of America | Sleep complaints | 112 patients diagnosed with TS (male-to-female ratio 3.8, mean age at onset 7.3, average duration of the symptoms 15.2 years; most of them treated with neuroleptics or tetrabenazine, 27 with clonidine, and 13 with clonazepam) | Prevalence of insomnia: 10.7% |
| Comings & Comings, 1987 | United States of America | Difficulty falling asleep or early awakening | 246 TS patients, 197 males, age ranges 2–75 years, mean age at onset 6.65 years; 39% have received treatment for ADHD or behavior problems | Prevalence of difficulty falling asleep: 49.6% (65.5% in severe TS) |
| Champion et al, 1988 | Canada | Problems getting to sleep | 210 patients diagnosed with TS. Age, sex, and treatments not specified | Prevalence of problems getting to sleep: 66% |
| Drake et al, 1992 | United States of America | Difficulty falling asleep. Clinical assessment and nocturnal sleep cassette EEG recording | 20 drug-free TS patients (8 treated previously; 14 males, age not specified, 7 had ADHD and 5 OCD) and 7 controls (6 males, age not specified) | Prevalence of difficulty falling asleep: in 45% |
| Wand et al, 1993 | Canada | Difficulty falling asleep | 422 TS patients (245 aged 6–17 years and 177 aged >17 years, male-to-female ratio 4:1, treatments not specified) | Prevalence of difficulty falling asleep: 29.7% for the two groups of age |
| Romano et al, 2004 | Assessment of sleep disorders using a standardized questionnaire including difficulty or refusal to go to sleep, difficulty falling asleep, distress, anxiety, or fear during drowsiness, startle episodes during drowsiness, rhythmic swing movements during drowsiness, and sweating episodes during drowsiness. | 40 children and 9 teenagers with tic disorders (TD) and in 893 age- and sex-matched controls. Treatment not specified | Difficulty or refusal to go to sleep (TD 54.1%, controls 29.7%) | |
| Ghosh et al, 2014 | United States of America | Insomnia | 123 patients diagnosed with TS (48 TS-only and 75 TS + ADHD; mean age 13.6 ± 3.8 years, range 6–21 years; male-to-female ratio 5:1 for TS-only and 3:1 for TS +ADHD). Treatment not specified | Prevalence of insomnia: 48.0% in TS-only patients and 77.1% in TS + ADHD (in 33.3% insomnia was related to drugs used for ADHD, specially methylphenidate and atomoxetine) |
| Moddafferi et al, 2016 | Assessment of sleep disorders using a standardized questionnaire including going to bed reluctantly, difficulty falling asleep at night, anxiety or fear when falling asleep, need for a transitional object, need for fluids or drugs to facilitate sleep, and myoclonic jerks on falling asleep. | 36 patients with TS (n=28) and chronic tic disorders (n=8) (30 males aged 8–16.3 years, mean 11.7 years, age at onset 3–10.5 years, mean 6.3 years; treatments not specified) and 266 age and sex-matched controls | Prevalence of going to bed reluctantly: 44.4% | |
| Lee et al, 2017 | Taiwan | Sleep disorders | 1124 under 18-year-old patients newly diagnosed with TS between 2001–2007 (76% male, most of them likely untreated) | Prevalence of insomnia: 0.3% (similar to that found in a control cohort −0.2%) |
| Isomura et al, 2021 | Sweden | Insomnia | 10.444.702 individuals aged 3 years or older living in Sweden between January 1, 1997, and December 31, 2013, excluding those with an organic brain disorder and/or epilepsy (5.877 with TS/CTD) | Prevalence of insomnia: 32.2% (30.8% in men, 37.1% in women) significantly higher than that found in subjects without TS/CTD (13.7%, 10.6% in men, 16.8% in women), with OR (95% CI) 6.82 (6.44–7.22), 7.23 (6.78–7.71), and 5.33 (4–74–5.99), respectively. |
Abbreviations: TS, Tourette syndrome; ADHD, Attention Deficit Hyperactivity Disorder; OCD, Obsessive-Compulsive Disorder; EEG, Electroencephalogram; EMG, Electromyogram; EOG, Electrooculogram; ECG, Electrocardiogram; REM, Rapid Eye Movements; NREM, Non-Rapid Eye Movements; PLMS, Periodic Limb Movements during Sleep; YGTCS, Yale Global Tic Severity Scale.
Summary of Frequency of Parasomnias in Patients Diagnosed with Tourette Syndrome
| Authors, Year Ref | Country | Study Subjects and Treatment | Confusional Arousals | Sleep Walking (Somnam-Bulism) | Sleep Talking | Sleep (Night) Terrors | Rem Sleep Behavior Disorder | Sleep Paralysis | Nightmare Disorder | Sleep Enuresis |
|---|---|---|---|---|---|---|---|---|---|---|
| Glaze et al, 1983 | United States of America | 14 untreated TS patients (9 men; 7 aged 8–19 years and 2 aged 48 years) and 11 healthy controls (10 men, 8 aged 8–16 years, and 3 adult men). Assessment of sleep disorders by PSG and video monitoring | 7/14 (50%) | NS/NA | NS/NA | NS/NA | NS/NA | NS/NA | NS/NA | NS/NA |
| Barabas et al, 1984 | United States of America | 57 patients with TS (50 boys, age 5–21 years, treatment not specified), 58 with seizures disorders, and 53 with learning disabilities. Assessment of sleep disorders using a standardized questionnaire | NS | 10/57 (17.5%) Significantly higher than in patients with seizure disorders and learning disabilities | NS/NA | 9/57 (15.8%) Significantly higher than in patients with seizure disorders and learning disabilities | NS/NA | NS/NA | NS/NA | 10/53 (18.9%) Significantly higher than in patients with seizure disorders |
| Barabas et al, 1984 | United States of America | 57 patients with TS (50 boys, age 5–21 years, treatment not specified), 57 with seizures disorders, and 57 with learning disabilities. Assessment of somnambulism using a standardized questionnaire | NS/NA | 10/57 (17.5%) Significantly higher than in patients with seizure disorders and learning disabilities | NS/NA | NS/NA | NS/NA | NS/NA | NS/NA | NS/NA |
| Erenberg et al, 1985 | United States of America | 58 patients with TS aged 15 to 25 years (average 17 years), sex and medication used were not specified. Assessment of specific sleep disorders using a standardized sleep questionnaire | NS/NA | 0/58 (0%) | 1/58 (1.7%) | NS/NA | NS/NA | NS/NA | 6/58 (46.2%) | 0/58 (10.3%) |
| Jankovic & Rohaidy, 1987 | United States of America | 34 TS patients recruited from a sample of 112 TZ patients with male-to-female ratio of 3.8, mean age at onset of 7.3, and an average duration of the symptoms of 15.2 years. Most of them were in treatment with neuroleptics or tetrabenazine, 27 with clonidine, and 13 with clonazepam. Assessment of sleep disorders through in-person interview and PSG | NS/NA | 9/112 (8%) | NS/NA | NS/NA | NS/NA | NS/NA | 6/112 (5.4%) | 19/112 (17%) |
| Comings & Comings, 1987 | United States of America | 246 TS patients, 197 males, age ranges 2–75 years, mean age at onset 6.65 years; 39% have received treatment for ADHD or behavior problems Assessment of specific sleep disorders using a standardized sleep questionnaire | NS/NA | 116/247 (46.9%) often or occasionally (14.9% in 47 controls) | 114/247 (46.2%) often or occasionally (56.9 in severe TS; 51.1% in 47 controls) | 112/247 (45.5%) often or occasionally (21.2% in 47 controls) | NS/NA | NS/NA | NS/NA | NS/NA |
| Champion et al, 1988 | Canada | Age, sex, and treatments not specified. Assessment of sleep disorders using a standardized question-naire sent to the parents | NS/NA | 42/210 (20%) | NS | 103/210 (49%) | NS/NA | NS/NA | NS/NA | 42/210 (20%) |
| Allen et al, 1992 | United States of America | 57 boys diagnosed with TS-only (mean age 11.6 ± 2.0 years, 47.4% under specific therapy); 89 boys with TS + ADHD (mean age 10.9 ± 1.9 years; 64.0% under specific therapy); 21 diagnosed with ADHD-only (mean age 10.4 ± 2.0; and 146 controls (mean age 10.8 ± 1.8). Assessment of specific sleep disorders using a standardized sleep behaviour questionnaire | NS/NA | Higher frequency in TS+ ADHD (23.9% of 89) than in controls (8.2% of 146). TS-only (20.0% of 57) and ADHD-only (25.0% of 21) similar to controls | Frequency significantly higher for TS + ADHD (52.3% of 89), TS-only (45.6% of 57), and ADHD-only (58.5% of 21) than for controls (22.8% of 146) | Frequency significantly higher in TS +ADHD (19.8% of 89) and in ADHD-only (20.0% of 21) than in TS-only (9.1% of 57) and controls (9.8% of 146) | NS/NA | NS/NA | Higher frequency in TS+ ADHD (40.2% of 89) than in controls (17.0% of 146). TS-only (29.8% of 57) and ADHD-only (20.0% of 21) showed similar frequency to controls | Higher frequency in TS+ ADHD (25.6% of 89) than in controls (11.3% of 146). TS-only (7.0% of 57) and ADHD-only (15.8% of 21) showed similar frequency to controls |
| Drake et al, 1992 | United States of America | 20 drug-free TS patients (8 treated previously; 14 males, age not specified, 7 had ADHD and 5 OCD) and 7 controls (6 males, age not specified). Clinical assessment and nocturnal sleep cassette EEG recording | NS/NA | 5/20 (25%) | 2/20 (10%) | NS/NA | NS/NA | NS/NA | 1/20 (5%) | 1/20 (10%) |
| Wand et al, 1993 | Canada | 422 TS patients (245 aged 6–17 years and 177 aged >17 years, male-to-female ratio 4:1, treatments not specified). Assessment of sleep disorders using a standardized questionnaire sent to the parents | NS/NA | 58/245 (23.7%) in TS aged 6–17 years 15/177 (8.5%) in <18 years | NS/NA | NS/NA | NS/NA | NS/NA | NS/NA | NS/NA |
| Ghosh et al, 2014 | United States of America | 123 TS patients (48 TS-only and 75 TS + ADHD; mean age 13.6 ± 3.8 years, range 6–21 years; male-to-female ratio 5:1 for TS-only and 3:1 for TS +ADHD; treatments not specified. Assessment of sleep disorders using a standardized question-naire | NS/NA | 11/48 (22.9%) in TS-only 14/75 (18.7%) in TS + ADHD | 23/48 (47.9%) in TS-only 50/75 (66.7%) in TS + ADHD | NS/NA | NS/NA | NS/NA | 8/48 (16.7%) in TS-only 28/75 (37.3%) in TS + ADHD | NS/NA |
| Modafferi et al, 2016 | Italy | 36 patients with TS (n=28) and chronic tic disorders (n=8) (30 males aged 8–16.3 years, mean 11.7 years, age at onset 3–10.5 years, mean 6.3 years; treatments not specified) and 266 age and sex-matched controls. Assessment of specific sleep disorders using a standardized sleep behaviour questionnaire | NS/NA | 2/36 (5.6%) in tic disorders vs 9/266 (3.4%) in controls (p =n.s.) | 8/36 (22.2%) in tic disorders vs 35/266 (13.1%) in controls (p=n.s,) | 1/36 (2.8%) in tic disorders vs 3/266 (1.1%) in controls (p= n.s.) | NS/NA | 2/36 (5.6%) in tic disorders vs 7/266 (2.6%) in controls (p=n.s.) | 3/36 (8.3%) in tic disorders vs 6/266 (2.3%) in controls (p=n.s.), 3/20 in tics disorders with low scores in the YGTSS (p>0.01 compared with controls) | NS/NA |
Notes: Adapted from Jiménez-Jiménez FJ, Alonso-Navarro H, García-Martín E, Agúndez JAG. Sleep Disorders in Tourette Syndrome. Sleep Med Rev. 2020 Oct;53:101335.8 With Permission from Elsevier.
Abbreviations: TS, Tourette syndrome; ADHD, Attention Deficit Hyperactivity Disorder; NREM, Non-Rapid Eye Movements; NS, Not Specified; NA, Not Assessed; REM, Rapid Eye Movements.